Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson’s disease.

Olivier Guillin, Nathalie Griffon, Erwan Bezard, Ludovic Leriche, Jorge Diaz, Christian Gross, Pierre Sokoloff
European Journal of Pharmacology. 2003-11-01; 480(1-3): 89-95
DOI: 10.1016/j.ejphar.2003.08.096

PubMed
Lire sur PubMed



Auteurs Bordeaux Neurocampus